BeyondSpring Competitors

BYSI Stock

USD 1.11 0.04 3.74%

BeyondSpring competes with Avadel Pharmaceuticals, AcelRx Pharmaceuticals, Codexis, Cumberland Pharmaceuticals, and Calyxt; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing BeyondSpring competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of BeyondSpring to its intrinsic valuation because they are able to contrast its competitors on a relative basis.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of BeyondSpring competition on your existing holdings. Check out BeyondSpring Correlation with its peers.For more detail on how to invest in BeyondSpring Stock please use our How to Invest in BeyondSpring guide.

The current Return on Average Assets is estimated to decrease to -0.88. The current Return on Average Equity is estimated to decrease to -1.23. BeyondSpring Average Assets are increasing as compared to previous years. The last year's value of Average Assets was reported at 103.4 Million. The current Tangible Asset Value is estimated to increase to about 101.3 M, while Asset Turnover is projected to decrease to 0.0143.

Specify up to 10 symbols:

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of BeyondSpring's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of BeyondSpring in the context of predictive analytics.

Hype

Prediction

Low	Estimated Value	High
0.06	1.11	9.42

Details

Intrinsic

Valuation

Low	Real Value	High
0.05	1.03	9.34

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as BeyondSpring. Your research has to be compared to or analyzed against BeyondSpring's peers to derive any actionable benefits. When done correctly, BeyondSpring's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in BeyondSpring.

BeyondSpring Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between BeyondSpring and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of BeyondSpring and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of BeyondSpring does not affect the price movement of the other competitor.

Related Correlations

	AVDL	ACRX	CDXS	CPIX	CLXT
AVDL		-0.82	-0.49	-0.51	0.73	AVDL
ACRX	-0.82		0.7	0.73	-0.56	ACRX
CDXS	-0.49	0.7		0.93	0.07	CDXS
CPIX	-0.51	0.73	0.93		0.0	CPIX
CLXT	0.73	-0.56	0.07	0.0		CLXT
	AVDL	ACRX	CDXS	CPIX	CLXT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

Nowadays, there is a big difference between BeyondSpring Stock performing well and BeyondSpring company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze BeyondSpring's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Information Ratio	Expected Shortfall	Potential Upside	Value At Risk	Maximum Drawdown
AVDL	3.24	0.57	0.18	1.22	3.08	0.15	(3.79)	7.74	(5.01)	21.93	Avadel Pharmaceuticals Profile Avadel Pharmaceuticals Dashboard Technical analysis Backtest News Timeline Analyst Consensus Fundamentals Trends
ACRX	3.89	(1.54)	0.00	(2.05)	0.00	(0.26)	0.00	7.58	(9.21)	31.04	AcelRx Pharmaceuticals Profile AcelRx Pharmaceuticals Dashboard Technical analysis Backtest News Timeline Fundamentals Trends
CDXS	3.30	(0.26)	0.00	(0.14)	0.00	(0.07)	0.00	6.42	(5.88)	23.45	Codexis Profile Codexis Dashboard Technical analysis Backtest News Timeline Analyst Consensus Fundamentals Trends
CPIX	2.32	(0.08)	0.00	(0.12)	0.00	(0.0216)	0.00	5.77	(3.82)	22.68	Cumberland Pharmaceuticals Profile Cumberland Pharmaceuticals Dashboard Technical analysis Backtest News Timeline Fundamentals Trends
CLXT	8.42	1.91	0.18	1.55	7.94	0.14	(12.57)	18.75	(13.33)	109.92	Calyxt Profile Calyxt Dashboard Technical analysis Backtest News Timeline Analyst Consensus Fundamentals Trends

Cross Equities Net Income Analysis

Compare BeyondSpring and related stocks such as Avadel Pharmaceuticals, AcelRx Pharmaceuticals, Codexis, Cumberland Pharmaceuticals, and Calyxt Inc Net Income Over Time

Select Fundamental

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

AVDL

(3.2 M)

(42.9 M)

(85.5 M)

41.8 M

(41.3 M)

68.3 M

(95.3 M)

(33.2 M)

7 M

(77.3 M)

(69.6 M)

(71.4 M)

ACRX

(33.4 M)

(23.4 M)

(33.4 M)

(24.4 M)

(43.2 M)

(51.5 M)

(47.1 M)

(53.2 M)

(40.4 M)

(35.1 M)

(31.6 M)

(34.1 M)

CDXS

(30.9 M)

(41.3 M)

(19.1 M)

(7.6 M)

(8.6 M)

(23 M)

(10.9 M)

(11.9 M)

(24 M)

(21.3 M)

(33.6 M)

(36.2 M)

CPIX

5.8 M

(2.1 M)

2.4 M

731.4 K

(944.7 K)

(8 M)

(7 M)

(3.5 M)

(3.3 M)

(3.5 M)

(5.6 M)

(5.7 M)

CLXT

(5.9 M)

(12.1 M)

(26 M)

(27.9 M)

(39.6 M)

(44.8 M)

(29.2 M)

(16.9 M)

(18.2 M)

BeyondSpring and related stocks such as Avadel Pharmaceuticals, AcelRx Pharmaceuticals, Codexis, Cumberland Pharmaceuticals, and Calyxt Inc Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in BeyondSpring financial statement analysis. It represents the amount of money remaining after all of BeyondSpring operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income to Non Controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

BeyondSpring Competitive Analysis

The better you understand BeyondSpring competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, BeyondSpring's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across BeyondSpring's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	BYSI	AVDL	ACRX	CDXS	CPIX	CLXT
	3.74 1.11 BeyondSpring	0.11 9.45 Avadel	8.57 0.76 AcelRx	1.79 3.83 Codexis	2.56 2.00 Cumberland	2.86 0.34 Calyxt
Market Volatility (90 Days Market Risk)	Abnormally volatile	Somewhat reliable	Somewhat reliable	Slightly risky	Risky	Out of control
Market Performance (90 Days Performance)	Very Weak	Good	Very Weak	Very Weak	Very Weak	Good
Odds of Financial Distress (Probability Of Bankruptcy)	Low	Below Average	Very High	Below Average	Close to Average	Close to Average
Current Valuation (Equity Enterprise Value)	Over Valued	Under Valued	Under Valued	Under Valued	Under Valued	Fairly Valued
Buy or Sell Advice (Average Analysts Consensus)	Sell	Buy	Buy	Strong Buy	Strong Buy	Hold
Trade Advice (90 Days Macroaxis Advice)	Cautious Hold	Strong Hold	Strong Sell	Hold	Strong Hold	Cautious Hold
Number of Shares Shorted	2.12 M	3.95 M	694.05 K	4.89 M	21.7 K	431.95 K
Shares Owned by Insiders	51.28 %	6.34 %	1.54 %	3.00 %	45.54 %	50.21 %
Current Ratio	4.96 X	2.72 X	1.81 X	4.84 X	1.80 X	1.88 X
Net Asset	81.65 M	247.26 M	77.89 M	41.04 M	91.42 M	22.42 M
Profit Margin	N/A	N/A	31.11 %	(0.24) %	(0.13) %	N/A
EBITDA	(60.46 M)	(102.27 M)	(30.83 M)	(23.07 M)	412.72 K	(15.36 B)
Operating Margin	(36.75) %	N/A	(21.02) %	(0.23) %	(0.14) %	(142.48) %
Current Valuation	(24.02 M)	456.22 M	15.64 M	302.73 M	29.34 M	14.13 M
Cash Flow from Operations	(47.24 M)	(77.31 M)	(30 M)	11.28 M	8.45 M	(19.36 M)
Retained Earnings	(222.55 M)	(422.1 M)	(408.58 M)	(369.44 M)	1.24 M	(125.27 M)
Current Asset	12.37 M	177.85 M	118.95 M	32.84 M	66.96 M	69.59 M
Beta	0.11	1.49	0.27	1.63	0.36	2.11
Price to Book	1.68 X	7.63 X	0.69 X	2.38 X	0.80 X	0.85 X
Shares Outstanding	38.96 M	61.78 M	8.2 M	65.95 M	14.4 M	49.54 M
Total Debt	3.58 M	142.4 M	5.01 M	46.11 M	16.2 M	13.67 M
Return On Equity	(1.47) %	(3.06) %	N/A	(0.22) %	(0.14) %	(1.58) %
Price to Earning	(8.63) X	61.46 X	0.39 X	(16.02) X	(16.05) X	(15.98) X
Z Score	3.8	1.0	-5.2	-6.6	0.6	N/A
Shares Owned by Institutions	15.46 %	54.88 %	19.65 %	93.96 %	17.65 %	4.98 %
Return On Asset	(0.42) %	(0.29) %	(0.33) %	(0.08) %	(0.0402) %	(0.47) %
Book Value Per Share	0.21 X	(0.20) X	3.68 X	2.20 X	2.52 X	0.15 X
Cash and Equivalents	72.37 M	104.12 M	22.92 M	90.11 M	18.22 M	7.03 M
Current Liabilities	2.06 M	59.19 M	12.78 M	14.84 M	11.69 M	5.28 M
Price to Earnings To Growth	N/A	0.07 X	N/A	(1.16) X	N/A	N/A
Total Asset	81.65 M	247.26 M	77.89 M	41.04 M	91.42 M	22.42 M
Short Ratio	10.37 X	7.05 X	2.66 X	7.30 X	1.76 X	1.48 X
Target Price	2.5	13.25	80.0	12.88	8.5	0.73
Price to Sales	62.24 X	44.83 X	11.80 X	2.73 X	0.79 X	4.03 X
Market Capitalization	41.68 M	583.19 M	5.74 M	255.87 M	28.36 M	17.35 M
Cash per Share	1.86 X	1.74 X	3.11 X	1.38 X	1.24 X	0.14 X
Net Income	(64.18 M)	(77.33 M)	(35.1 M)	(33.59 M)	(5.65 M)	(16.89 M)
Earnings Per Share	(1.02) X	(2.58) X	7.60 X	(0.51) X	(0.37) X	(0.40) X
Debt to Equity	0.14 %	2.63 %	0.43 %	0.29 %	0.50 %	1.54 %
Revenue	1.35 M	N/A	2.82 M	138.59 M	42.01 M	157 M
Working Capital	10.3 M	118.67 M	106.17 M	18 M	55.28 M	64.31 M
Gross Profit	1.35 M	16.59 M	(5.03 M)	20.46 M	32.89 M	157 K
Day Typical Price	1.1	9.46	0.72	3.88	1.99	0.34
Accumulation Distribution	1837.67	8131.39	50816.05	18668.51	168.99	20020.67
Market Facilitation Index	0.0	0.0	N/A	N/A	0.0	N/A
Daily Balance Of Power	0.3333	0.0313	0.5	(0.41)	0.8333	(0.33)
Rate Of Daily Change	1.04	1.0	1.09	0.98	1.03	0.97
Day Median Price	1.09	9.47	0.7	3.91	1.98	0.35
Price Action Indicator	0.04	(0.015)	0.09	(0.11)	0.045	(0.01)
Coefficient Of Variation	(1,105)	702.96	(378.95)	(1,405)	(3,877)	741.08
Mean Deviation	6.43	3.24	3.89	3.3	2.32	8.42
Jensen Alpha	(0.82)	0.5699	(1.54)	(0.26)	(0.08)	1.91
Total Risk Alpha	(0.64)	0.6592	(1.41)	(0.20)	(0.012392)	2.23
Sortino Ratio	N/A	0.1754	N/A	N/A	N/A	0.177
Downside Variance	N/A	11.05	N/A	N/A	N/A	115.22
Standard Deviation	9.58	4.0	5.86	4.2	3.3	13.98
Kurtosis	3.17	0.6101	3.65	0.5139	3.34	17.96
Potential Upside	14.15	7.74	7.58	6.42	5.77	18.75
Treynor Ratio	(0.40)	1.22	(2.05)	(0.14)	(0.12)	1.55
Maximum Drawdown	51.93	21.93	31.04	23.45	22.68	109.92
Variance	91.73	16.0	34.34	17.63	10.91	195.41
Market Risk Adjusted Performance	(0.39)	1.23	(2.04)	(0.13)	(0.11)	1.56
Risk Adjusted Performance	(0.08)	0.143	(0.24)	(0.06)	(0.017419)	0.1377
Skewness	(0.24)	0.538	(0.007847)	(0.23)	(0.25)	3.14
Semi Deviation	N/A	3.08	N/A	N/A	N/A	7.94
Information Ratio	(0.09)	0.1457	(0.26)	(0.07)	(0.021601)	0.1359
Value At Risk	(14.20)	(5.01)	(9.21)	(5.88)	(3.82)	(13.33)
Expected Short fall	N/A	(3.79)	N/A	N/A	N/A	(12.57)
Downside Deviation	N/A	3.32	N/A	N/A	N/A	10.73
Semi Variance	N/A	9.49	N/A	N/A	N/A	63.06

BeyondSpring Competition Performance Charts

Five steps to successful analysis of BeyondSpring Competition

BeyondSpring's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by BeyondSpring in relation to its competition. BeyondSpring's competition analysis typically involves several steps, including::

Identifying the key players in the market: This involves identifying the major competitors of BeyondSpring in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact BeyondSpring's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to BeyondSpring, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your BeyondSpring position

In addition to having BeyondSpring in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Electronic Equipment Thematic Idea Now

Electronic Equipment

Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Electronic Equipment theme has 61 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electronic Equipment Theme or any other thematic opportunities.

View All Next

Launch

Check out BeyondSpring Correlation with its peers.For more detail on how to invest in BeyondSpring Stock please use our How to Invest in BeyondSpring guide. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for analysis

When running BeyondSpring price analysis, check to measure BeyondSpring's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeyondSpring is operating at the current time. Most of BeyondSpring's value examination focuses on studying past and present price action to predict the probability of BeyondSpring's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BeyondSpring's price. Additionally, you may evaluate how the addition of BeyondSpring to your portfolios can decrease your overall portfolio volatility.

	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios

Is BeyondSpring's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeyondSpring. If investors know BeyondSpring will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeyondSpring listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.02)

Revenue Per Share

0.035

Return On Assets

(0.42)

Return On Equity

(1.47)

The market value of BeyondSpring is measured differently than its book value, which is the value of BeyondSpring that is recorded on the company's balance sheet. Investors also form their own opinion of BeyondSpring's value that differs from its market value or its book value, called intrinsic value, which is BeyondSpring's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeyondSpring's market value can be influenced by many factors that don't directly affect BeyondSpring's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between BeyondSpring's value and its price as these two are different measures arrived at by different means. Investors typically determine BeyondSpring value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeyondSpring's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

Working Capital	Tangible Assets Book Value per Share
Tangible Asset Value	Sales per Share
Return on Sales	Return on Invested Capital
Return on Average Equity	Return on Average Assets
Price to Sales Ratio	Price Sales Damodaran Method
Price to Earnings Ratio	Price Earnings Damodaran Method
Price to Book Value	Payout Ratio
Profit Margin	Market Capitalization
Invested Capital Average	Invested Capital
Gross Margin	Foreign Currency to USD Exchange Rate
Free Cash Flow per Share	Free Cash Flow
Enterprise Value over EBITDA	Enterprise Value over EBIT
Enterprise Value	Average Equity
Earnings per Basic Share USD	Earnings per Diluted Share
Earnings per Basic Share	Earnings before Tax
Earnings Before Interest Taxes and Depreciation Amortization USD	EBITDA Margin
Earnings Before Interest Taxes and Depreciation Amortization EBITDA	Dividends per Basic Common Share
Dividend Yield	Debt to Equity Ratio
Current Ratio	Book Value per Share
Asset Turnover	Average Assets
Total Assets Per Share	Net Assets Per Share
Cash Flow Per Share	Revenue Per Employee
Net Income Per Employee	Return on Investment
Operating Margin	Calculated Tax Rate
Receivables Turnover	Inventory Turnover
PPandE Turnover	Cash and Equivalents Turnover
Accounts Payable Turnover	Accrued Expenses Turnover
Interest Coverage	Long Term Debt to Equity
Quick Ratio	Net Current Assets as percentage of Total Assets
Revenue to Assets

BeyondSpring Competitors

Specify up to 10 symbols:

BeyondSpring Competition Correlation Matrix

Related Correlations

Risk-Adjusted Indicators

Cross Equities Net Income Analysis

BeyondSpring and related stocks such as Avadel Pharmaceuticals, AcelRx Pharmaceuticals, Codexis, Cumberland Pharmaceuticals, and Calyxt Inc Net Income description

BeyondSpring Competitive Analysis

BeyondSpring Competition Performance Charts

Five steps to successful analysis of BeyondSpring Competition

Complement your BeyondSpring position

Did You Try This Idea?

Run Electronic Equipment Thematic Idea Now

Electronic Equipment

Complementary Tools for analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY